Enteral nutrition in critically ill patients under vasoactive drug therapy: The NUTRIVAD study

Abstract

Background Enteral nutrition (EN) in critically ill patients requiring vasoactive drug (VAD) support is controversial. This study assesses the tolerability and safety of EN in such patients. Methods This prospective observational study was conducted in 23 intensive care units (ICUs) over 30 months. Inclusion criteria were a need for VADs and/or mechanic circulatory support (MCS) over a minimum of 48 h, a need for ≥48 h of mechanical ventilation, an estimated life expectancy >72 h, and ≥72 h of ICU stay. Patients with refractory shock were excluded. EN was performed according to established protocols during which descriptive, daily hemodynamic and efficacy, and safety data were collected. An independent research group conducted the statistical analysis. Results Of 200 patients included, 30 (15%) required MCS and 145 (73%) met early multiorgan dysfunction criteria. Mortality was 24%. Patients needed a mean dose of norepinephrine in the first 48 h of 0.71 mcg/kg/min (95% CI, 0.63–0.8) targeting a mean arterial pressure of 68 mm Hg (95% CI, 67–70) during the first 48 h. EN was started 34 h (95% CI, 31–37) after ICU admission. Mean energy and protein delivered by EN/patient/day were 1159 kcal (95% CI, 1098–1220) and 55.6 g (95% CI, 52.4–58.7), respectively. Daily energy balance during EN/patient/day was −432 (95% CI, −496 to −368). One hundred and fifty‐four (77%) patients experienced EN‐related complications. However, severe complications, such as mesenteric ischemia, were recorded in only one (0.5%) patient. Conclusion EN in these patients seems feasible, safe, and unrelated to serious complications. Reaching the energy target only through EN is difficult.

Significant Published Articles in 2022 for Pharmacy Nutrition Support Practice

“…Eight papers from the primary literature (receiving 5 or more votes) were collectively identified as the most important by the author group. 11 -18 Results from the sorting process are depicted in Figure 1.…”

“… Flordelis Lasierra et al 14 Enteral nutrition in critically ill patients under vasoactive drug therapy: The NUTRIVAD study. …”

Enteral feeding tolerance during pharmacologic neuromuscular blockade

“…Depending on the volatility of the patient's hemodynamic status and required dosage of the vasopressors, enteral feeding may be interrupted. 6,32 Another issue in evaluating feeding tolerance for patients who receive NMB is that many of the studies examining feeding intolerances and techniques designed to improve nutrient delivery often had a small number of patients from the total population (eg, <10%) who…”

Acute mesenteric ischaemia

“…Reignier et al showed that AMI occurred more often in patients with shock receiving full enteral nutrition vs. full parenteral nutrition (PN) [51]. The more recent study applied enteral nutrition below estimated needs in patients with vasopressors and observed AMI in 1/200 patients (0.5%) [52]. Experimental data support caution toward (full) enteral nutrition in patients at risk of AMI, showing that preoperative fasting protected against intestinal ischemia/reperfusion injury and improved survival in mice [53 ▪▪ ].…”